Combatting Counterfeit Medicines in Nigeria’s Healthcare

In Nigeria’s healthcare landscape, trust is not assumed. It is earned, and often fragile. At the centre of that trust is a simple expectation: that the medicines people rely on are safe, effective, and authentic.

Yet the data tells a more complex story. Estimates suggest that a significant proportion of medicines circulating in Nigeria may be substandard or counterfeit, with some industry bodies warning that this could exceed 50% in parts of the market. Across Africa more broadly, studies indicate that roughly 1 in 5 medicines fail basic quality tests, contributing to hundreds of thousands of preventable deaths annually.

This is not just a regulatory issue. It is a systemic one, affecting patient safety, treatment outcomes, and overall confidence in healthcare delivery.

Counterfeit medicines introduce uncertainty into care. A patient may receive the right diagnosis and prescription, yet experience poor outcomes because the medication itself is compromised. Over time, this erodes trust not only in providers but in the system as a whole. Historically, the scale of the problem has been severe, with some estimates suggesting counterfeit drugs once accounted for a substantial share of medicines in Nigeria’s market.

Several structural factors continue to sustain this challenge. Fragmented supply chains, weak enforcement, and the proliferation of informal drug outlets create entry points for counterfeit products. In fact, inadequate inspection, poor cross-border enforcement, and weak collaboration between regulatory bodies have all been identified as key drivers of the problem. At the same time, economic pressure and rising drug costs push many patients toward cheaper, unverified alternatives.

Addressing this requires a coordinated approach that reinforces quality at every stage, from production and importation to distribution and dispensing.

READ ALSO – Access to Quality Medication as a Measure of Healthcare Progress

Regulatory bodies such as the National Agency for Food and Drug Administration and Control (NAFDAC) have made measurable progress over the years, reducing counterfeit prevalence through stricter monitoring and post-market surveillance. However, the persistence of the problem highlights that regulation alone is not enough. It must be complemented by stronger supply chain visibility, faster verification systems, and consistent enforcement.

Pharmacies and primary care providers remain central to this effort. As the final point of contact, they act as both access points and assurance points. Research consistently highlights the critical role pharmacists play in detecting and preventing counterfeit medicines, despite gaps in detection capacity still existing.

Technology is also emerging as a key enabler. Authentication tools, digital tracking systems, and enhanced inventory management can significantly reduce ambiguity throughout the supply chain, making it more difficult for counterfeit products to circulate undetected.

Ultimately, the fight against counterfeit medicines in Nigeria is not only about eliminating bad actors. It is about building a system where quality is consistent, verifiable, and trusted. Because when patients can rely on the medicines they receive, trust stabilises. And when trust is present, the healthcare system does not just function. It delivers.